Patient confidentiality

Patient confidentiality is the stated reason Vic Chakravarty gives for not disclosing information about Palinurus Maciver Junior’s health. In the investigation, that professional boundary is also treated as a clue: the possibility of an undisclosed brain tumour could explain the death and affect the validity of the will, while Chakravarty’s connection to a beneficiary complicates his silence.

The Rule as Stated

When Tom Lockridge tries to learn what Chakravarty knows, he reports that the doctor said he had nothing to tell him and that, even if he did, patient confidentiality would be his watchword. Lockridge takes the pointed reference to confidentiality as evidence that there may be something to protect. That interpretation is an inference, not proof: invoking a duty of secrecy does not itself establish that relevant medical information exists.

The distinction matters because Lockridge is not asking out of detached curiosity. He wants Chakravarty to disclose information that might help Sue-Lynn Maciver overturn the will. His account of the exchange turns confidentiality into both an obstacle and a possible signpost. The principle limits access to the patient’s health information; in the hands of someone pursuing a legal advantage, that limit can appear to conceal precisely the evidence he hopes to obtain.

Pressure to Disclose

Lockridge asks Edgar Wield to lean on Chakravarty, but Wield questions both whether he can do so and whether he should. He has no clear reason to pressure the doctor, and he has seen the post-mortem report, which contains no mention of a tumour. His response contrasts Lockridge’s instrumental aim with the constraints on using confidential medical information to advance a will challenge.

Lockridge argues that a tumour could supply a motive for suicide and strengthen Sue-Lynn’s case that Palinurus Maciver Junior was not mentally sound when he changed his will. To explain why the condition might have gone undetected, he points to the catastrophic damage to the dead man’s head: the brain was fragmented, with portions on the desk and floor. His reasoning is that there may have been no intact tissue left to examine for a tumour. This is Lockridge’s explanation for the missing post-mortem finding, not a general rule about medical examinations or proof, by itself, that the tumour existed.

The Medical Secret and the Will

The later discussion confirms that Palinurus Maciver Junior had an inoperable brain tumour, despite its absence from the post-mortem report. It also reveals that Chakravarty had been involved with Cressida Maciver, the dead man’s sister. The medical secret therefore has consequences beyond the doctor-patient relationship: disclosure might assist the widow’s challenge to the will, but could also require Chakravarty to give evidence in a dispute affecting someone close to him.

Peter Pascoe explains why the doctor may have kept silent after learning of the suicide. Tom Lockridge had approached him and made clear that information about a possibly diseased brain could help Sue-Lynn Maciver contest the will. The new will named Cressida Maciver among its main beneficiaries, making the prospect of testifying for the plaintiff against her unattractive to Chakravarty. Patient confidentiality is thus not presented as the sole explanation for his silence. It provides a genuine professional boundary, while his personal relationship and the stakes of the will dispute offer an additional, self-interested disincentive.

Narrative Function

The rule’s significance lies in the uncertainty surrounding its invocation. At first, Lockridge treats Chakravarty’s appeal to confidentiality as a giveaway; Wield, by contrast, refuses to treat suspicion as sufficient reason to intrude and notes that the post-mortem offers no support for the tumour theory. Later revelations validate the suspicion that important medical information existed, but they also uncover a separate reason for Chakravarty’s reluctance to speak.

This sequence keeps the ethical and investigative questions distinct. The eventual discovery of the tumour explains why the information mattered, but it does not turn confidentiality into a convenient obstacle that can simply be set aside. Nor does Chakravarty’s affair with Cressida erase the possibility that he was also observing a duty to his patient. The investigation instead shows how professional secrecy, a contested inheritance, and personal loyalties can converge, making silence both ethically intelligible and open to suspicion.